US Stock MarketDetailed Quotes

ZTS Zoetis

Watchlist
  • 157.520
  • -7.410-4.49%
Close Feb 14 16:00 ET
  • 158.020
  • +0.500+0.32%
Post 20:01 ET
70.54BMarket Cap28.80P/E (TTM)

About Zoetis Company

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Company Profile

SymbolZTS
Company NameZoetis
Listing DateFeb 1, 2013
Issue Price26.00
Founded1952
CEOMs. Kristin C. Peck
MarketNYSE
Employees14100
Fiscal Year Ends12-31
Address10 Sylvan Way
CityParsippany
ProvinceNew Jersey
CountryUnited States of America
Zip Code07054
Phone1-973-822-7000

Company Executives

  • Name
  • Position
  • Salary
  • Kristin C. Peck
  • Director and Chief Executive Officer
  • 15.24M
  • Jeannette Ferran Astorga
  • Executive Vice President, Corporate Affairs, Communications and Chief Sustainability Officer
  • --
  • Jamie Brannan
  • Executive Vice President and Chief Commercial Officer
  • --
  • Wetteny Joseph
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 4.25M
  • Roxanne Lagano
  • Chief Human Resources Officer, Executive Vice President, Global Operations and Interim General Counsel and Corporate Secretary
  • --
  • Julie Fuller
  • Executive Vice President, Global Operations and Chief Human Resources Officer
  • --
  • Keith Sarbaugh
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • Rimma Driscoll
  • Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
  • --
  • Dr. Robert J. Polzer, PhD
  • Executive Vice President and President, Research and Development
  • 2.44M
  • Nick Ashton
  • Executive Vice President and President, Global Manufacturing and Supply
  • --
  • Michael B. McCallister
  • Non-Executive Chairman of the Board
  • 490.00K
  • Jared Shriver
  • President, U.S. Operations
  • --
  • Gavin D.K. Hattersley
  • Director
  • --
  • Gregory Norden
  • Independent Director
  • 365.00K
  • Louise M. Parent
  • Independent Director
  • 370.00K
  • Robert W. Scully
  • Independent Director
  • 365.00K
  • Paul M. Bisaro
  • Independent Director
  • 340.00K
  • Frank A. D'Amelio
  • Independent Director
  • 340.50K
  • Antoinette R. Leatherberry
  • Independent Director
  • 340.00K
  • Dr. Willie M. Reed
  • Independent Director
  • 370.00K
  • Vanessa Broadhurst
  • Independent Director
  • 341.00K
  • Sanjay Khosla
  • Independent Director
  • 340.00K

Trending Stocks

Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More